RU RU Brachytherapy of the prostate Prostate cancer Prostatectomy History of the issue Indications for brachytherapy Contraindications Implantation Advantage disadvantages Hygienic Requirements for Ensuring Radiation Safety Brachytherapy authorization Medical centers news 09 July 2015 The production of microsources for the treatment of prostate cancer is presented at Innoprom 2015 in Yekaterinburg 02 June 2015 First brachytherapy operation for prostate cancer performed in Armenia May 27, 2015 Igor Shuvalov and Andrey Vorobyov got acquainted with the results of the activities of OOO "Bebig" April 28, 2015 Modern technologies and treatment methods in oncourology were discussed in Tyumen April 15, 2015 Conference "Topical issues of urology. Diseases of the prostate gland. New technologies in urology." 02 April 2015 Leading oncologists from all over the world have gathered in Irkutsk. All news History of the issue Brachytherapy was first used in 1910, when D. Pasto and P. Degre introduced capsules of radium-226 into the prostate gland through the urethra. Further, in 1917 in the USA, B. Barringer introduced microsources into the gland through needles. Then R. Phlox together with co-authors in 1930 used radioactive gold as an implant. The revival of prostate cancer brachytherapy began in 1970 with the development of I-125 retropubical open seed implantation technology at New York Memorial Hospital. However, with the open retropubical technology, the iodine grains were placed manually, as a result of which the optimal dose distribution in the prostate gland was not achieved: along with the zones of excessive activity, cold foci remained. In 1981, H. Holm and J. Gammelgard applied the technology of implantation of micro-sources of iodine-125 into prostate tissue under the control of transrectal ultrasound scanning (TRUS). This technique was first used to obtain a biopsy, and it became apparent that it could be used to visualize the position of radioactive sources in the prostate. This served as the basis for the new technology of brachytherapy. In 1990, P. Kutrevelis used a three-dimensional stereotactic attachment to a computed tomography (CT) scanner to treat prostate cancer patients who could not be treated with TRUS-guided brachytherapy. In 2000, a new method of treating prostate cancer - brachytherapy - was introduced at the Research Institute of Urology of the Ministry of Health of Russia in Moscow. This institute became the first medical institution in Russia to master brachytherapy - a unique technology known and applied all over the world. Since 2004, the method of Professor P. Kutrevelis (conducting brachytherapy under the control of CT) has been used at the Brachytherapy Center at the Medical Radiological Scientific Center of the Russian Academy of Medical Sciences in Obninsk. © 2006-2015 Bebig Ltd. All rights reserved. Russia, 123458, Moscow, st. Tvardovskogo, 8 Tel./fax: +7 (495) 780-92-68, 780-92-69 Site creation: ALISA.design